STUDYING OF POTENTIAL ANXIOLYTIC ACTIVITY OF ANGELICA ADZHARICA M. PIMEN. METHANOLIC EXTRACT
DOI:
https://doi.org/10.52340/jecm.2022.07.47Keywords:
angelica adzharica, extract, anxiolytic effect, zebrafish larvaeAbstract
Anxiety disorders have become the number one mental health issue in developed countries. The number of people living with anxiety and depressive disorders rose significantly because of the COVID-19 pandemic. Although generally considered as safe and effective, the currently available anxiolytic therapy is responsible for numerous side effects and addiction. Therefore, there is an imperious demand for discovering more efficient and cheaper new groups of pharmaceuticals (“green anxiolytic”). There is a big number of research, studying plants containing coumarins as active compounds, especially those belonging to the Apiaceae family. Laboratory studies already suggest the anti-anxiety activity of various extracts of Angelica Archangelica. Therefore, the aim of our study was to obtain the methanolic extract of Angelica adzharica and evaluate the potential anxiolytic effect based on the zebrafish larvae model. According to our knowledge, this is the first report studying the anxiolytic effect of Angelica adzharica extract based on the zebrafish larvae.
Downloads
References
Baxter, A.J.; Scott, K.M.; Vos, T.; Whiteford, H.A. Global prevalence of anxiety disorders: A systematic review and meta-regression. Psychol. Med. 2012, 43, 897–910
Brandao, M.L.; Vianna, D.M.; Masson, S.; Santos, J. Neural organization of different types of fear: Implication for the understanding of anxiety. Rev. Bras. Psiquiatr. 2003, 25, 36–41
Budzynska, B., Kruk-Slomka, M., Skalicka-Wozniak, K., Biala, G., Glowniak, K., 2012. The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice. Exp. Clin. Psychopharmacol. 20, 325-332.
Budzyńska, Barbara; Kruk-Słomka, Marta; Skalicka-Woźniak, Krystyna; Michalak, Agnieszka; Biała, Grażyna; Głowniak, Kazimierz (2013). Anxiolytic action of imperatorin from Angelica officinalis. Pharm Rep, 65, 32–33
Gagnidze, R. Manvelidze, Z. "Angelica adzharica". The IUCN Red List of Threatened Species. IUCN.2014
Herrera-Ruiz, M., Gonzalez-Carranza, A., Zamilpa, A., Jimenez-Ferrer, E., Huerta-Reyes, M., Navarro-Garcia, V.M., 2011. The standardized extract of Loeselia mexicana possesses anxiolytic activity through the gamma-amino butyric acid mechanism. J. Ethnopharmacol. 138, 261-267
Kohlmunzer, S., 2007. Farmakognozja: podręcznik dla studentów farmacji (Warszawa: Wydawnictwo Lekarskie PZWL)
Kumar, Dinesh; Bhat, Zulfiqar Ali; Shah, M.Y. (2012). Anti-anxiety activity of successive extracts of angelica archangelica linn. on the elevated t-maze and forced swimming tests in rats. Journal of Traditional Chinese Medicine, 32(3), 423–429
Lydiard, R.B. The role of GABA in anxiety disorders. J. Clin. Psychiatry 2003, 64, 21–27
Mental Health and COVID-19: Early evidence of the pandemic’s impact. Geneva: WHO; 2022.
Moitra M, Santomauro D, Collins PY, Vos T, Whiteford H, Saxena S, et al. The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: a systematic review and Bayesian meta-regression analysis. PLoS Med. 2022;19(2)
Monika Maciąg, Agnieszka Michalak, Krystyna Skalicka-Woźniak, Maria Zykubek, Andrzej Ciszewski, Barbara Budzyńska,Zebrafish and mouse models for anxiety evaluation – A comparative study with xanthotoxin as a model compound,Brain Research Bulletin,Volume 165,2020,Pages 139-145
Muniandy, Y. The use of larval zebrafish (Danio rerio) model for identifying new anxiolytic drugs from herbal medicine. Zebrafish 2018, 15, 321–339
O’Brien, C.O., 2005. Benzodiazepine use, abuse, and dependence. Journal of Clinical Psychiatry 66, 28–33
Olatunji, B.O., Cisler, J.M., Tolin, D.F., 2007. Quality of life in the anxiety disorders: a meta-analytic review. Clinical Psychology Review 27, 572–581
Shader, R.I.; Greenblatt, D.J. Use of benzodiazepines in anxiety disorders. N. Engl. J. Med. 1993, 328, 1398–1405
Schnorr, S.J.; Steenberger, P.J.; Richardson, M.K.; Champagne, D.L. Measuring thigmotaxis in larval zebrafish. Behav. Brain Res. 2012, 228, 367–374
Singhuber, J., Baburin, I., Ecker, G.F., Kopp, B., Hering, S., 2011. Insights into structureactivity relationship of GABAA receptor modulating coumarins and furanocoumarins. Eur. J. Pharmacol. 668, 57-64
Somers, J.M., Goldner, E.M., Waraich, P., Hsu, L., 2006. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Canadian Journal of Psychiatry 51, 100–113
Venugopala, K.N., Rashmi, V., Odhav, B., 2013. Review on natural coumarin lead compounds for their pharmacological activity. Biomed. Res. Int. 2013, 963248
Whiting, P.J., 2003. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discovery Today 8, 445–450
Widelski, J.; Luca, S.V.; Skiba, A.; Maci ˛ag, M.; Budzy ´nska, B.; Marcourt, L.; Wolfender, J.-L.; Skalicka-Wo ´zniak, K. Coumarins from Seseli devenyense Simonk.: Isolation by Liquid–Liquid Chromatography and Potential Anxiolytic Activity Using an In Vivo Zebrafish Larvae Model. Int. J. Mol. Sci. 2021, 22, 1829
Downloads
Published
How to Cite
Issue
Section
